Skip to main content
OpenTrials

Clinical trial condition

Early Stage Triple-Negative Breast Carcinoma

Explore clinical trials studying Early Stage Triple-Negative Breast Carcinoma. Study availability and eligibility vary by location and protocol.

9 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Early Stage Triple-Negative Breast Carcinoma trial results

Recruiting

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

NCT05812807

Conditions
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, +1 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Thomas Hospital Fairhope, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
View all 846 locations
View Trial Details
Recruiting

Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer

NCT07017673

Conditions
Breast Diseases, Breast Neoplasms, Early Stage Triple-Negative Breast Carcinoma, +7 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Cedars-Sinai Medical Center Beverly Hills Los Angeles, California, United States
  • Huntington Cancer Center, an Affiliate of CS Cancer Pasadena, California, United States
  • Hunt Cancer Institute, an Affiliate of CS Cancer Torrance, California, United States
View Trial Details
Recruiting

Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer

NCT06324240

Conditions
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, +31 more
Locations
  • Grady Health System Atlanta, Georgia, United States
  • Emory University Hospital Midtown Atlanta, Georgia, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • Emory Saint Joseph's Hospital Atlanta, Georgia, United States
View Trial Details
Recruiting

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

NCT05929768

Conditions
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +2 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 963 locations
View Trial Details
Not yet recruiting

Phase II Trial of Pembrolizumab/Chemotherapy With Live Biotherapeutic Product MO-03 in Patients With Early Stage Triple Negative Breast Cancer

NCT07552181

Conditions
Breast Diseases, Breast Neoplasms, Early Stage Triple-Negative Breast Carcinoma, +7 more
Locations
  • Cedars-Sinai Medical Center Beverly Hills Beverly Hills, California, United States
  • CS Cancer at Valley Oncology Medical Group Tarzana, California, United States
  • Hunt Cancer Institute, an Affiliate of CS Cancer Torrance, California, United States
View Trial Details

Related conditions